Omics and bioinformatics approaches to identify novel antigens for vaccine investigation and development

13Citations
Citations of this article
20Readers
Mendeley users who have this article in their library.

Abstract

Despite the outstanding technological advances achieved in the last few decades, infectious diseases remain a major societal challenge. From the variolation carried out in ancient China during the 15th century to the more advanced RNA and DNA vaccines presently available, vaccines have been proven as highly effective therapeutic tools to combat various infectious diseases. Vaccine research and development is now empowered with recent advances in Omics sciences and the developments of powerful bioinformatics tools. This Special Issue has gathered a total of nine original papers, including seven research papers and two reviews, illustrating the use of Omics data and bioinformatics in the research, design and development of vaccines against pathogens and cancer. The integration of knowledge from Omics and Bioinformatics will certainly boost vaccine research and development, leading to novel therapeutic tools against new and old pathogens and cancer in the near future.

Cite

CITATION STYLE

APA

Leitão, J. H., & Rodríguez-Ortega, M. J. (2020, December 1). Omics and bioinformatics approaches to identify novel antigens for vaccine investigation and development. Vaccines. MDPI AG. https://doi.org/10.3390/vaccines8040653

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free